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Abstract
Background: Rates of colonization and infection with multidrug-resistant (MDR) bacteria are increasing worldwide,
in both acute care hospitals and long-term care facilities (LTCFs). Italy has one of the highest prevalence of MDR
bacteria in European countries, especially with regard to methicillin-resistant Staphylococcus aureus (MRSA) and
extended-spectrum β-lactamase (ESBL) or carbapenemase producing Enterobacteriaceae (CPE).
Method: Review of studies on colonization by MDR bacteria from Italian LTCFs, risk factors for colonization and
molecular characteristics of surveillance and clinical isolates, compared with other European countries.
Results: High variability of MDR colonization has been reported within and especially between European countries.
Only a few surveillance studies have been performed in Italian LTCFs; these show MRSA colonization prevalence of
7.8–38.7 % for residents and 5.2–7.0 % for staff members, ESBL prevalence of 49.0–64.0 % for residents and 5.2–14.
5 % for staff and prevalence of CPE of 1.0–6.3 % for residents and 0.0–1.5 % for staff. In Italian LTCFs, as well as in
other European countries, the most prevalent ESBLs from surveillance or clinical Escherichia coli isolates were found
to be CTX-M-type enzymes, particularly CTX-M-15, expressed by the pandemic ST131 clonal group; this lineage also
expresses carbapenemase genes of the blaVIM and blaKPC types. Various risk factors for colonization of residents by
MDR bacteria were identified.
Conclusions: The limited data from Italian LTCFs confirms these settings as important reservoirs for MDR organisms,
allowing important considerations regarding the infection risk by these organisms. Nevertheless, more extended and
countrywide screening studies for MDR colonization in Italian LTCFs are required. To promote further studies of various
microbiological aspects related to LTCFs, the Association of Italian Clinical Microbiologists (Associazione Microbiologi
Clinici Italiani; AMCLI) in 2016 has set up a new Working Group for the Study of Infections in LTCFs (Gruppo di Lavoro
per lo Studio delle Infezioni nelle Residenze Sanitarie Assistite e Strutture Territoriali assimilabili; GLISTer), consisting of
Clinical Microbiologists represented by the authors of this review article.
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Background
As in other European countries the aging population in
Italy represents an increasing public health priority. Long-
term care facilities (LTCF), according to the definition
used in this review article, are facilities (nursing homes,
inpatient behavioral health facilities, and long-term
chronic care hospitals) that help meet both the medical
and non-medical needs of elderly people with a chronic
illness or disability, involving various levels of medical care
that require the expertise of skilled practitioners. The
older, sicker residents cared for in LTCFs have a variety of
risk factors for colonization and also for infection with
multidrug-resistant (MDR) organisms, increasing their
morbidity and mortality [1]. Antibiotics are among the
most commonly prescribed classes of medications for
LTCF residents, increasing the selection pressure for
MDR bacteria [2]. Cross-transmission within these facil-
ities is also promoted, owing to various factors such as
permanent living in a confined environment, the difficulty
of diagnosing infections that present atypically and
because of the frequent cognitive impairment of residents,
reducing the compliance with basic hygiene measures. For
these and other reasons LTCFs are a potentially important
reservoir for MDR organisms [1, 3].
The aim of this review is to summarize the colonization
prevalence studies of LTCF residents and staff published
from Italian LTCFs and to compare them with studies from
other European countries. MDR bacteria considered in this
review are methicillin-resistant Staphylococcus aureus
(MRSA), vancomycin resistant enterococci (VRE),
extended-spectrum β-lactamase (ESBL) and/or carbapene-
mase producing Enterobacteriaceae (CPE). Furthermore,
the main bacterial genotypes and resistance genes circulat-
ing in Italian LTCFs are reviewed. Finally, major risk fac-
tors for colonization by MDR bacteria identified in Italian
LTCFs, compared with other European countries, are
discussed.
Literature search
We adopted a search strategy in the Medline/Pubmed
database including the following search terms: (nursing
home* OR long term care facilit*) AND (colonization OR
multi drug resistan* OR ESBL OR MRSA OR VRE OR
carbapenemase*). We restricted the search to the date
range 01.01.2000–30.08.2016 but did not impose any
language restriction. Applying this search strategy we
identified 641 articles and retrieved 14 full-text Italian and
68 full-text European non-Italian studies. Moreover, we
included a poster referred to Italian LTCFs (reporting
colonization prevalence and typing results), presented
at the 26th European Congress of Clinical Microbiology
and Infectious Diseases (ECCMID), in the reference list.
Overall, we included 28 LTCF colonization studies from
European non-Italian countries in the review; only 2
studies investigated carriage with CPE and 4 studies
assessed the colonization by VRE, while 20 studies
described MRSA carriage and 12 studies reported
colonization by ESBL producers. Furthermore, we in-
cluded 6 colonization studies from Italy, comprising 5
studies reporting MRSA, 4 studies describing ESBL, 3
studies investigating CPE and only 1 study referred to
colonization by VRE. Eleven studies from the Medline/
Pubmed search reported molecular characterization of
Italian LTCF isolates (comprising one study reporting
typing of MRSA); from the reference lists of the articles
we retrieved two further Italian studies reporting
molecular characterization data of isolates. Exclusion
criteria for reviewing of colonization rates were studies
that selected for clinical isolates or were referred to
outbreak investigations, whereas similar studies were
included in the analysis of resistance gene types and in
typing of isolates; a structured review of the molecular
characterization of isolates was done only for Italian
LTCF isolates. At least two authors screened every ab-
stract and full-text article and they discussed the results
with all other authors before they were included in the
review article.
Colonization of residents and staff by MDR bacteria in
European LTCFs
Rates of colonization and infection with MDR bacteria
are increasing worldwide, in both acute care hospitals
and LTCFs [1–3]. Colonization rates by MRSA and
ESBL producing Enterobacteriaceae in European LTCFs
are summarized in Table 1; the surveys are quite hetero-
geneous in terms of facility sizes, resident characteristics
and specimen types and therefore direct comparison
between different studies is subject to bias. Nevertheless,
high variability of colonization frequency for ESBL pro-
ducing Enterobacteriaceae and MRSA, ranging from
close to zero up to levels higher than 50 % can be
derived from these studies; variability is high especially
among countries but also among different LTCFs within
single countries. Recently, the emergence and worldwide
spread of CPE has generated an immediate infection
threat to residents in LTCFs, but we found only two
European colonization studies reporting low colonization
prevalence; 0.0 % in a study from Ireland [4] and 0.3 % in a
study from the Netherlands [5]. Colonization by VRE in
European LTCF residents was found to be low, ranging
from 0.0 % in Belgium [6], 0.4 % [7] and 2.7 % [8] in
Germany, up to 3 % in Ireland [4]. LTCF staff colonization
by MRSA in European LTCFs was found as high as 7.5 %
in Ireland [9] and 0.0–5.2 % in Slovenia [10].
Italy has one of the highest prevalence of MDR bacteria
isolated from blood cultures in European countries, espe-
cially with regard to MRSA and ESBL- or carbapenemase-
producing Enterobacteriaceae [11] and residence in a LTCF
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is an independent risk factor for MDR blood stream
infections [12]. In spite of the importance of LTCFs
as reservoirs for MDR organisms, in Italian LTCFs only a
few colonization studies have been performed during the
last 10 years (Table 2). These surveys show MRSA
colonization prevalence of 7.8–38.7 % for residents and
5.2–7.0 % for staff, ESBL prevalence of 49.0–64.0 % for resi-
dents and 5.2–14.5 % for staff, and CPE prevalence of 1.0–
6.3 % for residents and 0.0–1.5 % for staff. Colonization by
VRE is rare, with 2.7 % of residents found in one study [13].
All Italian and all except three European studies
included in the review are point prevalence studies
(Tables 1 and 2). Unfortunately, in many of these
colonization studies, the only sample type for MRSA screen-
ing were nasal swabs, but by using exclusively this specimen
type screening sensitivities of only 50–60 % are reached, with
possible significant underestimation of the real colonization
frequency; on the other hand the only use of rectal swabs for
ESBL screening, as done in most of the colonization studies,
permits still high sensitivity of 77–96 % [13, 14]. Screening
for CPE in two of the three Italian colonization studies
was done on chromogenic ESBL agar plates [13, 14];
this non-specific carbapenemase screening could have
impacted on the sensitivity of the method. Finally, Italian
colonization data refers mainly to a limited number of
LTCFs, located in northern provinces of the country; be-
cause it is not appropriate to extrapolate data from Northern
Italy to the central and southern part of the country, more
extended and countrywide colonization studies are required.
Molecular characterization of MDR Enterobacteriaceae and
MRSA from surveillance or clinical samples of Italian LTCFs
ESBL producing Escherichia coli isolates frequently
belong to the pandemic clonal-group ST131 (mainly the
H30-ST131 sub-clone) [15]; the association of this
lineage with LTCFs has been widely documented [16]. In
Table 1 Colonization of European LTCF residents with MRSA and ESBL producing Enterobacteriaceae
Country, year Residents/LTCFs (number) Specimen type MRSA % (range %) ESBL % (range %) Referencesa
Sweden, 2008 495/9 Rectal 0.0 3.0 [54]b
Sweden, 2010 163/1 Catheter Urine 0.6 [55]
Sweden, 2014 91/10 Rectal 11 [56]b
Netherlands, 2009 1268/12 Nasal 0.3 [57]
Netherlands, 2012–14 4763 (MRSA),
5421 (ESBL)/107
Nasal (MRSA)
Urine (ESBL, E. coli)
0.3 2.2 [51]
Germany, 2009 1827/32 Nasal and/or wound 7.6 (0–18.6) [45]
Germany, 2010–11 240/11 Rectal 9.6 (0–30) [18]
Germany, 2012 150/8 MRSA: nasal, pharyngeal ESBL: perineal 9.2 26.7 [8]
Germany, 2013 690/26 (MRSA),
455/26 (ESBL)
Nasal, pharyngeal, perineal 6.5 17.8 [7]
Germany, 2013–14 2858/65 Nasal, pharyngeal 4.8 (0–26.7) [46]
Germany, 2013–14 156/31 Rectal 14.7 [19]
Luxembourg, 2010 954/19 Nasal, pharyngeal 7.2 (0–16) [49]
Slovenia, 2001–02 107/1 Nasal and skin 9.3 [10]
France, 2004 109/1 Nasal, rectal 37.6 [52]
France, 2013 1155/38 Rectal or urine 9.9 (0.0–28.6) [58]
Belgium, 2005 2953/60 Nasal, pharyngeal, wound, urine 19.5 (2.0–42.9) [47]
Belgium, 2011 2791/60 Nasal, pharyngeal, wound, rectal 12.2 (0–36) 6.2 (0–20) [6]
Spain, 2003 413/4 Nasal, skin 22.5 (17.2–35.5) [59]
Spain, 2005 1377/9 Nasal 16.8 (6.7–35.8) [60]
Spain, 2009–10 744/17 Nasal 19.6 [61]
UK, 2005 715/39 Nasal 22.2 (0–50) [42]
UK, 2005–07 3037/69 Nasal 20 (19–21) [43]
UK, 2006–09 2492/65 Nasal 20.5 [44]
Ireland, 2004–06 294/16 Rectal (only E. coli) 40.5 (0–75) [17]
Ireland, 2005–06 1111/45 Nasal 23.3 (0–73) [9]
Ireland, 2012–13 64/1 Nasal, rectal, urine 27 55 [4]b
aAll studies are point prevalence studies, except three (b) that follow residents over three months [56], two years [54] or one year [4], respectively
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European LTCFs the clonal E. coli ST131 group
frequently expresses ESBL genes belonging to various
CTX-M-types (prevalently CTX-M-15) [4, 17–19]. Simi-
larly, as shown in Table 3, in Italian LTCFs the most
prevalent ESBLs in E. coli were found to be CTX-M-
type enzymes (79–97 %), particularly CTX-M-15, and
these E. coli mainly belonged to the ST131 clonal group
[14, 20–22]; in a study of isolates from 12 LTCFs the
H30-ST131 subclone strongly predominated (71 %) [23].
On the other hand, ESBLs in Klebsiella pneumoniae are
mainly encoded by blaCTX-M or blaSHV-12 genes,
whereas the ESBL phenotype of Proteus mirabilis and
Morganella morganii isolates is generally due to pro-
duction of the TEM-92 enzyme; high prevalence of the
plasmidic AmpC-type enzyme CMY-16 was also found
in P. mirabilis [14, 20, 22, 24, 25].
Sporadic or epidemic carbapenemase producing Entero-
bacteriaceae have been reported from European LTCF
residents: K. pneumoniae expressing the carbapenemase
OXA-48 from the Netherlands [5], E. coli and K. pneumo-
niae producing K. pneumoniae carbapenemase 2 (KPC-2)
from Greece [26], K. pneumoniae producing KPC-3 from
Portugal [27] and K. pneumoniae producing New Delhi
metallo-β-lactamase-1 (NDM-1) from Poland [28]. The
prevalent carbapenemase-types in enterobacterial isolates
from Italian LTCFs are the Verona integron-encoded
metallo-β-lactamase-1 (VIM-1) and various KPC types
(Table 3). VIM-1 carbapenemases have been found to be
expressed from various species of Enterobacteriaceae, iso-
lated from acute-care hospitals and LTCFs in the Province
of Bolzano [29, 30]; in this setting the blaVIM-1 gene is
located on plasmids of various sizes, but with the same
framework and all belonging to the incompatibility group
IncN [31]. In Italian LTCFs VIM-1 enzymes have been
found to be associated with E. coli belonging to the clonal
group ST131 [14, 29]; subtyping of 2 isolates identified
them as the subclone H30 ST131 [32]. Moreover, in a
long-term care and rehabilitation facility in Milan an out-
break caused by an ST131 E. coli strain, associated with
blaKPC-2 and blaKPC-8 genes located on plasmids belonging
to the IncF group, has been identified [33]. KPC-
producing Enterobacteriaceae are widely distributed in
LTCFs of countries like the USA with high prevalence of
this resistance phenotype [34]. KPC-producing K. pneu-
moniae are epidemically diffused in Italy, mostly belonging
to the clonal complex 258 [35], yet in a study involving
489 residents from 12 LTCFs only 5 isolates were found to
produce carbapenemases (1.0 % of residents colonized); of
these isolates 3K. pneumoniae harbored blaKPC-3 and 2 E.
coli carried blaVIM-1 [23]. Further sporadic KPC-2 produ-
cing K. pneumoniae isolates from LTCF residents were
found by other authors [36]. Finally, an outbreak of
NDM-1 producing K. pneumoniae in a nursing home in
Northern Italy has been identified [37].
Finally, the emergence of the transferable colistin resist-
ance determinant mcr-1 has most recently been reported in
commensal E. coli isolates from three Italian LTCFs [38].
MRSA isolates from an Italian LTCF were all negative
for Panton-Valentine leukocidin (PVL) and belonged
prevalently to ST8, spa t008, SCCmec IV [39]; this MRSA
type is also prevalent in isolates from acute care hospitals
in Northern Italy [40, 41]. In LTCF residents of other
European countries various predominant MRSA types
have been found: ST22, spa t022 or t032 (EMRSA-15) in
the United Kingdom [42–44] and Ireland [9], the same
MRSA type together with ST5, spa t003 (EMRSA-3) in
Germany [45, 46], ST45, SCCmec IV in Belgium [47] and
ST146, SCCmec IV in Spain [48]. Livestock-associated
Table 2 Colonization of Italian LTCF residents and staff with MRSA and multi-drug resistant Enterobacteriaceae
Province, year No. of residents (R),









Bergamo, 2005 R (88), S (51), L (1) 83/80 Nasal MRSA (19.3) MRSA (5.8) [39]
Vicenza, 2006 R (551), L (2) 83/73 Nasal MRSA (7.8) [62]
Various provincesb,
2006
R (221), L (23) 83/61 Catheter urine ESBL/AmpC (54.0) [22]


























R (489), L (12) 85/69 Rectal, nasal,
axillary
ESBL (57.3) Carbapenemase
KPC-3/VIM-1 (1.0) MRSA (17.2)
[23]
aAll studies are point prevalence studies; b 70 % Northern Italy, 5 % Central Italy, 25 % Southern Italy; c one of the LTCFs was screened in 2008 and 2012;
carbapenemase screening was done on chromogenic ESBL agar plates; d 50 % Northern Italy, 50 % Central Italy
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Table 3 Characteristics of MDR Enterobacteriaceae isolated from surveillance or clinical samples of Italian LTCF residents or staff
Italian Province, year Bacterial species Resistance gene (number of isolates) Clonal group (number of isolates) References
ESBL or high-level AmpC producing Enterobacteriaceae
Pavia, 2003–04 E. coli blaCTXM (61) [21]
blaSHV-5 (1)
blaTEM (15)




Lodi, 2009–10 blaCTXM (61) [20]
blaSHV-type (2)




Various provinces, 2006 K. pneumoniae blaCTXM (6) [22]
blaTEM-151 (1)
Lodi, 2009–10 blaCTXM-15 (11) [20]
Bolzano, 2012 blaSHV-12 (9) [14]
blaCTXM-15 (1)
Pavia, 2004–05 P. mirabilis blaTEM-92 (23) [25]
blaCMY-16 (3)
Pavia, 2003–06 ESBL (197) [24]
blaCMY-16 (20)
Various provinces, 2006 blaTEM-92 (23) [22]
blaTEM-92 + blaCMY-16 (4)
blaTEM-4 (9)
blaTEM-24 (1)
Lodi, 2009–10 blaTEM-92 (10) [20]
blaCMY-16 (15)
Bolzano, 2012 blaTEM-92 (17) [14]
blaCMY-16 (1)
Various provinces, 2006 M. morganii blaTEM-92 (14) [22]
Bolzano, 2012 blaTEM-92 (10) [14]
Various provinces, 2015 E. coli Not reported H30-ST131 (175) [23]
Carbapenemase producing Enterobacteriaceae
Bolzano, 2008–12 E. coli blaVIM-1 (14) Typing of 3 E. coli: all ST131;
1 E. coli subtyped: H30-ST131
[13, 14, 29, 30, 32]
K. pneumoniae blaVIM-1 (5)
Klebsiella oxytoca blaVIM-1 (4)
M. morganii blaVIM-1 (1)
P. mirabilis blaVIM-1 (1)
Providencia stuartii blaVIM-1 (1)
Bologna, 2011 K. pneumoniae blaNDM-1 (4) [37]
Milan, 2011–13 E. coli blaKPC-2 (9) ST131 (8) [33]
blaKPC-3 (1)
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MRSA (LA-MRSA) genotypes belonging to CC398 have
also sporadically been found in European LTCFs [49],
whereas the isolation of PVL producing MRSA isolates
has not yet been reported [9, 43, 44, 48].
Risk factors for colonization by MDR organisms of
residents in Italian and other European LTCFs
Residents of LTCFs are uniquely vulnerable to colonization
by MDR organisms and infection with these bacteria,
because of the frequent and simultaneous presence of
major risk factors [1, 50]; various of these risk factors have
been found in screening studies in Italy and other Euro-
pean countries (Table 4). Particularly, the previous admin-
istration of antibiotics, especially fluoroquinolones and
extended-spectrum cephalosporins, the presence of inva-
sive medical devices, older age and the degree of depend-
ence on nursing care, expressed as physical disability, are
associated with colonization by MDR organisms. A strik-
ing feature is the high colonization of LTCF staff with
MDR bacteria; this carriage probably reflects resident-to-
staff, and, perhaps, staff-to-staff transmission [13]. LTCF
residents frequently depend on continuous nursing care
for daily living activities, with many occasions for horizon-
tal transmission of MDR-organisms between residents
and health care workers (resident-to-staff and staff-to-
resident transmission). The length of stay in a LTCF is also
a major risk factor, suggested by the higher colonization
rates in LTCF residents compared with acute care hospital
Table 4 Risk factors for colonization of Italian and other European LTCF residents with ESBL producing Enterobacteriaceae and/or
MRSA






High age ESBL, MRSA [13] [8, 9, 60]
Male sex ESBL, MRSA [6, 9, 42, 46]
Physical disability, bedridden, low functional status ESBL, MRSA [13, 23] [6, 8, 45–47, 49, 59–61]
Prolonged duration of stay in LTCF MRSA [23]
Invasive medical devices (urinary catheter, percutaneous enteral
gastrostomy tube, tracheostomy tube)
ESBL, MRSA [13, 20] [7, 8, 42, 45, 46, 52, 59, 60]
Previous administration of antibiotics within the preceding year ESBL, MRSA [13, 20, 62] [6, 7, 17, 47–49, 51, 52, 54, 58–61]
Colonization history by the same microorganism ESBL, MRSA [6, 7, 46, 49, 59, 61]
MDR bacteria carriage of other residents MRSA [46, 51]
Multiple room occupancy, MDR carrier in the same room MRSA [46]
Residency in specific unit within LTCF ESBL, MRSA [13, 14, 62]
Prior admission to acute care hospital ESBL, MRSA [20, 62] [42, 45–47, 58, 60, 61]
Surgical procedures within 30 days ESBL [20]
Cancer ESBL, MRSA [13, 62] [58]
Decubitus ulcer ESBL, MRSA [22] [46, 48, 59, 60]
Various wounds, skin lesions MRSA, ESBL [6, 8, 45–47, 59]
Peptic ulcer, use of antiacids ESBL, MRSA [20] [6]
Chronic renal failure ESBL [20]
History of urinary tract infections ESBL [17]
Urinary and faecal incontinency ESBL, MRSA [23] [8, 58]
Chronic obstructive pulmonary disease (COPD) ESBL, MRSA [13, 20]
Diabetes ESBL [20] [8]
Table 3 Characteristics of MDR Enterobacteriaceae isolated from surveillance or clinical samples of Italian LTCF residents or staff
(Continued)
blaKPC-8 (1)
Cuneo, 2013 E. coli blaVIM-1 (1) H30- ST131 (1) [32]
Valle d’Aosta, 2013–14 K. pneumoniae blaKPC-2 (6) ST1789 (6) [36]
Various provinces, 2015 K. pneumoniae blaKPC-3 (3) [23]
E. coli blaVIM-1 (2)
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patients [13]. Moreover, the strict application of hospital
hygiene measures in LTCFs is difficult because they are
homes of the residents and therefore social interactions
are encouraged. Previous hospitalization of LTCF resi-
dents is a further risk factor for colonization with MDR
bacteria because patients can be admitted to the LTCF
already colonized with MDR organisms acquired in the
hospital [1]; surgical procedures and various chronic dis-
eases and medications may increase the frequency of con-
tact of LTCF residents with the health care system and
facilitate the colonization and infection with MDR organ-
isms. Interestingly, in a Dutch study authors found that
the presence of MRSA carriers in the LTCFs more than
doubled the likelihood of finding ESBL-producing E. coli
[51]; this might be explained by similar transmission ways
of these MDR organisms among LTCF residents. Finally,
several further facility specific risk factors have been de-
scribed, comprising lack of infection control policy, inad-
equate staffing and high staff turnover, increased number
of residents per bedroom and the presence of limited facil-
ities for hand washing [1].
Conclusions
LTCFs are important reservoirs for MDR organisms and
colonization rates are similar or even higher than those
found in acute care hospitals [13, 14], but the great vari-
ability in the number of residents and staff members and
in the methods used for screening make it difficult to dir-
ectly compare the results of various colonization studies.
Nevertheless, colonization prevalence with MDR bacteria
of LTCF residents has been found to be highly variable,
reaching values as high as 37.6 % in France for MRSA
[52] and as high as 55-75 % in Ireland for ESBL produ-
cing Enterobacteriaceae [4, 17]. In the few published
surveillance studies in Italian LTCF residents similarly
high ESBL colonization rates have been reported, whereas
MRSA colonization was lower. Especially worrying is the
emergence of carbapenemase producers in these facilities,
expanding the reservoir of this health care threat.
Colonization is frequently the prerequisite for infections
[53]; this has many implications with regard to hospital
hygiene measures and therefore reinforced infection con-
trol and surveillance programs are urgently needed,
though their application in this specific setting is challen-
ging [1]. Engaging of LTCFs in antimicrobial stewardship
programs, frequently set up in acute care hospitals, is also
a critical “hot topic”, focusing on drivers for antimicrobial
over-use [2].
Data referred to baseline colonization by MDR bacteria in
the Italian LTCF setting is not representative of the whole
country and therefore the performance of proper country-
wide screening studies is required; moreover, a standardized
screening protocol is recommended. For this reason and to
promote further studies of various microbiological aspects
related to LTCFs, the Association of Italian Clinical Microbi-
ologists (Associazione Microbiologi Clinici Italiani; AMCLI)
in 2016 has set up a new Working Group for the Study of
Infections in LTCFs (Gruppo di Lavoro per lo Studio delle
Infezioni nelle Residenze Sanitarie Assistite e Strutture
Territoriali assimilabili; GLISTer), consisting of Clinical
Microbiologists represented by the authors of this review
article. The mission of this group is also to support infection
prevention and control initiatives in Italian LTCFs, with the
aim to reduce the spread of MDR bacteria within and across
acute and chronic health care facilities.
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